期刊文献+

多个生物标志物预测宫颈上皮内瘤和宫颈癌的风险 被引量:6

Predicting Progression of Cervical Intraepithelial Neoplasia,and Prognosis of Cervical Cancer with a Panel of Biomarkers Tested in Multivariate Modeling
原文传递
导出
摘要 目的:研究生物蛋白指标是否可以作为宫颈癌和高分级宫颈上皮内瘤样病变(CIN)的肿瘤标志物。方法:采用免疫组织化学方法检测包括宫颈内皮瘤和宫颈癌在内的292例标本中9个蛋白指标的表达,包括E-钙粘素(E-cadherin),细胞外信号调节激酶-1(ERK-1),基质金属蛋白酶-2(MMP-2),nm23-H1,核因子NF-κB,p16INK4A,存活素(survivin),人端粒酶逆转录酶(hTERT),血管内皮生长因子(VEGF-C),然后采用统计方法进行分析,构建变量模型,计算反映指标,与靶受体反应的特征曲线进行比较,确定上述蛋白标记物在预测宫颈癌存活率以及高分级CIN的作用。结果:所有个标记物中,nm23-H1及p16 INK4a对宫颈癌的生存率的单变量分析有明显的意义,在对所有标记物做细致详尽的分析后发现,其中3个标记物(E-钙粘素、VEGF-C、survivin)可对高分级的CIN进行预测。宫颈癌的生存率的有效的预测因子中,只有nm23-H1可以作为有效的预测因素。结论:联合检测多个生物蛋白,如E-钙粘素、VEGF-C、survivin指标可以有效的预测高危CIN的恶变风险,同时nm23-H1则可以为宫颈癌的预后提供参考。 Objective: To investigate if the 9 markers would be independent predictors of intermediate end point markers in cervical carcinogenesis.Methods: 9 markers(E-cadherin,ERK-1,MMP-2,nm23-H1,NF-κB,p16INK4A,survivin,hTERT,VEGF-C)were Immunohistochemical(IHC) stained,then multivariate models were constructed to test predictive power of the markers for 2 outcomes.Results: In all the markers,the most powerful predictors of CIN2(and above) lesions were E-cadherin,VEGF-C,survivin.The nm23-H1 was significant predictor of CC survival in univariate analysis.Conclusions: Combining multiple markers can accurate detection of high-grade CIN in a clinical setting,and the markers could be the indicators for the survival of cervical cancer.
出处 《现代生物医学进展》 CAS 2012年第10期1930-1933,共4页 Progress in Modern Biomedicine
关键词 宫颈癌 生物标志物 宫颈上皮内瘤 Cervical cancer Biomarkers CIN
  • 相关文献

参考文献1

  • 1Branca M, Giorgi C, Santini D, et al. Aberrant expression of a novel inhibitor ofapoptosis (Survivin) is related to grade of cervical intraepithelial neoplasia (CIN), but does not predict virus clearance after cone or prognosis in cervical cancer [J]. Am J Clin Pathol, 2005,124: 113-121. 被引量:1

同被引文献88

  • 1吴瑾,唐良萏.宫颈癌前病变与生物标志物[J].国外医学(妇幼保健分册),2005,16(3):181-183. 被引量:3
  • 2Naumnik W, Nilklifiska W, OssoMska M, et al. Serum levels ofHMGB1, survivin, and VEGF in patients with advanced non - smallcell lung cancer duringchemotherapy [ J]. Folia Histochem Cytobiol,2009,47(4):703 -709. 被引量:1
  • 3de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus gen-otype attribution in invasive cervical cancer: a retrospective cross - sec-tional worldwide study[ J]. Lancet Oncol,2010,11(11) :1048 - 1056. 被引量:1
  • 4Perentes JY,Kirkpatrick ND,Nagano S, et al. Cancer cell - associatedMT1 - MMP promotes blood vessel invasion and distant metastasis in tri-ple -negativemammary tumors[ J]. Cancer Res,2011,71 (13) :4527-4538. 被引量:1
  • 5Parkin DM,Bray F,Ferlay J,et al.Global Cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108. 被引量:1
  • 6Kamangar F,Dores GM,Anderson WF.Patterns of cancer inci-dence,mortality,and prevalence across five continents:definingpriorities to reduce cancer disparities in different geographicregions of the world[J].J Clin Oncol,2006,24(14):2137-2150. 被引量:1
  • 7Ogawa E,Okuyama R,Ikawa S,et al.p51/p63 inhibits ultravioletB-induced apoptosis via Akt activation[J].Oncogene,2008,27(6):848-856. 被引量:1
  • 8Shai A,Pitot HC,Lambert PF.p53 loss synergizes with estrogenand papillomaviral oncogenes to induce cervical and breast cancers[J].Cancer Res,2008,68(8):2622-2631. 被引量:1
  • 9Malinowski DP.Multiple biomarkers in molecular oncology.Ⅰ.Molecular diagnostics applications in cervical cancer detection[J].Expert Rev Mol Diagn,2007,7(2):117-131. 被引量:1
  • 10Balasubramanian A,Hughes J,Mao C,et al.Evaluation of anELISA for p16INK4a as a screening test for cervical cancer[J].Cancer Epidemiol Biomarkers Prev,2009,18(11):3008-3017. 被引量:1

引证文献6

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部